A phase I study of daunorubicin in advanced untreatable malignancies.
D000328:Adult; D000368:Aged; D001769:Blood / Q000187:drug effects; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
D003630:Daunorubicin